All innovations will be presented at JFR 2019 on the Intrasense ™ booth (# 213A). The new version of Myrian® as well as the XP-Mammo application will be display.
This new version of Myrian® brings many clinical innovations and a new application.
Achieving a positive Net Income within this first 2019 semester validates the strategic choices set by the new governance in 2018, generating profits for the first half of 2019 financial year.
Myrian® XP-Mammo, can now be commercialized on the European market.
Myrian® XP Prostate, the new reference tool for worldwide prostate experts.